Solstein Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Sell |
248
-41
| -14% | -$21.5K | 0.07% | 134 |
|
|
2025
Q1 | $183K | Sell |
289
-10
| -3% | -$6.34K | 0.11% | 101 |
|
|
2024
Q4 | $213K | Hold |
299
| – | – | 0.12% | 91 |
|
|
2024
Q3 | $314K | Hold |
299
| – | – | 0.17% | 83 |
|
|
2024
Q2 | $314K | Sell |
299
-72
| -19% | -$75.7K | 0.21% | 78 |
|
|
2024
Q1 | $357K | Hold |
371
| – | – | 0.25% | 71 |
|
|
2023
Q4 | $326K | Hold |
371
| – | – | 0.24% | 72 |
|
|
2023
Q3 | $305K | Sell |
371
-12
| -3% | -$9.88K | 0.26% | 71 |
|
|
2023
Q2 | $275K | Buy |
383
+30
| +8% | +$21.6K | 0.23% | 72 |
|
|
2023
Q1 | $290K | Buy |
353
+89
| +34% | +$73.1K | 0.25% | 72 |
|
|
2022
Q4 | $190K | Sell |
264
-16
| -6% | -$11.5K | 0.16% | 93 |
|
|
2022
Q3 | $193K | Buy |
280
+5
| +2% | +$3.45K | 0.17% | 82 |
|
|
2022
Q2 | $163K | Sell |
275
-5
| -2% | -$2.96K | 0.12% | 112 |
|
|
2022
Q1 | $196K | Sell |
280
-738
| -72% | -$517K | 0.13% | 114 |
|
|
2021
Q4 | $643K | Buy |
1,018
+969
| +1,978% | +$612K | 0.39% | 71 |
|
|
2021
Q3 | $30K | Hold |
49
| – | – | 0.02% | 276 |
|
|
2021
Q2 | $27K | Buy |
49
+2
| +4% | +$1.1K | 0.03% | 269 |
|
|
2021
Q1 | $22K | Buy |
+47
| New | +$22K | 0.03% | 248 |
|
|
2020
Q4 | – | Sell |
-47
| Closed | -$26K | – | 179 |
|
|
2020
Q3 | $26K | Hold |
47
| – | – | 0.06% | 163 |
|
|
2020
Q2 | $29K | Hold |
47
| – | – | 0.07% | 146 |
|
|
2020
Q1 | $23K | Hold |
47
| – | – | 0.09% | 133 |
|
|
2019
Q4 | $18K | Buy |
+47
| New | +$18K | 0.04% | 204 |
|